Rhoda Eniafe

Molecular and flow cytometric characterization of the CD4 and CD8 T‐cell repertoire in patients with myelodysplastic syndrome

D. Follmann, J. Melenhorst, A. Barrett, 2002, British journal of haematology.

Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies.

Marcela R. Uribe, S. Adams, A. Barrett, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.

K. Rezvani, K. Keyvanfar, A. Barrett, 2009, Blood.

Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator–responder pairs

A. Barrett, N. Hensel, G. Sconocchia, 2003, Bone Marrow Transplantation.

T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57.

D. Follmann, A. Barrett, J. Molldrem, 2003, The hematology journal : the official journal of the European Haematology Association.

Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies

K. Rezvani, A. Barrett, S. Mielke, 2011, Haematologica.

Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy

K. Rezvani, R. Childs, S. Mielke, 2012, Cancer Immunology, Immunotherapy.

Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein

K. Rezvani, K. Keyvanfar, A. Barrett, 2010, Leukemia.